What are the Future Directions for FDA Regulation of Nanotechnology?
The FDA is continually evolving its regulatory approach to keep pace with advancements in nanotechnology. Future directions may include:
Developing more sophisticated methods for assessing the safety and efficacy of nanomaterials. Enhancing collaboration with international regulatory agencies to harmonize standards. Incorporating advanced technologies such as artificial intelligence and machine learning to improve risk assessments. Engaging with stakeholders, including industry, academia, and the public, to foster transparency and trust.
